Life Science REIT plc Stock

Equities

LABS

GB00BP5X4Q29

Residential REITs

Market Closed - London S.E. 11:35:29 2024-04-26 EDT 5-day change 1st Jan Change
39.1 GBX +0.51% Intraday chart for Life Science REIT plc +2.89% -38.13%

Financials

Sales 2024 * 19.3M 24.17M 32.99M Sales 2025 * 23.87M 29.88M 40.79M Capitalization 137M 171M 234M
Net income 2024 * 10M 12.52M 17.09M Net income 2025 * 14M 17.53M 23.93M EV / Sales 2024 * 13.8 x
Net Debt 2024 * 130M 163M 223M Net Debt 2025 * 147M 184M 251M EV / Sales 2025 * 11.9 x
P/E ratio 2024 *
12.6 x
P/E ratio 2025 *
9.54 x
Employees -
Yield 2024 *
7.03%
Yield 2025 *
7.57%
Free-Float 93.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.51%
1 week+2.89%
Current month-0.51%
1 month-0.51%
3 months-34.83%
6 months-36.94%
Current year-38.13%
More quotes
1 week
38.00
Extreme 38
39.90
1 month
37.00
Extreme 37
42.00
Current year
37.00
Extreme 37
65.00
1 year
37.00
Extreme 37
77.40
3 years
37.00
Extreme 37
106.00
5 years
37.00
Extreme 37
106.00
10 years
37.00
Extreme 37
106.00
More quotes
Members of the board TitleAgeSince
Director/Board Member 59 22-05-02
Director/Board Member 62 -
Director/Board Member 63 21-10-13
More insiders
Date Price Change Volume
24-04-26 39.1 +0.51% 4,418,664
24-04-25 38.9 +0.78% 255,554
24-04-24 38.6 -1.53% 564,054
24-04-23 39.2 +1.29% 672,084
24-04-22 38.7 +1.84% 284,287

Delayed Quote London S.E., April 26, 2024 at 11:35 am

More quotes
Life Science REIT plc is a United Kingdom-based closed-ended real estate investment trust. The Company seeks to invests in a diversified portfolio of properties across the United Kingdom, which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. It acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. It retains flexibility to acquire individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in or providing a benefit to, the life science sector. Its investment adviser is Ironstone Asset Management Limited.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.391 GBP
Average target price
0.6067 GBP
Spread / Average Target
+55.16%
Consensus

Annual profits - Rate of surprise